Tokyo, May 8 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061473) titled 'A Multicenter Observational Study of Carbon-ion Radiotherapy for Squamous Cell Carcinoma of the Nasal Cavity and Paranasal Sinuses' on May 7.
Study Type:
Observational
Primary Sponsor:
Institute - National Institutes for Quantum Science and Technology
Condition:
Condition - Primary Squamous Cell Carcinoma of the Nasal Cavity and Paranasal Sinuses
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the safety and efficacy of carbon-ion radiotherapy in patients with primary squamous cell carcinoma of the nasal cavity and paranasal sinuses
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1) Histologically confirmed primary squamous cell carcinoma of the nasal cavity or paranasal sinuses.
2) Regional lymph node status of N0-N2 at the start of carbon-ion radiotherapy.
3) No evidence of distant metastasis.
4) Deemed unsuitable for surgical resection of the primary tumor.
5) Received carbon-ion radiotherapy with curative intent.
6) At least one measurable lesion.
7) An Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 at the initiation of treatment.
Key exclusion criteria - 1) Patients who declined the use of their data after public disclosure of this study (opt-out).
Target Size - 100
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 04 Month 01 Day
Date of IRB - 2026 Year 04 Month 01 Day
Anticipated trial start date - 2026 Year 05 Month 08 Day
Last follow-up date - 2028 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070340
Disclaimer: Curated by HT Syndication.
